Literature DB >> 20607418

Lymph-vascular space invasion as a significant risk factor for isolated para-aortic lymph node metastasis in endometrial cancer: a study of 203 consecutive patients.

Suk-Joon Chang1, Tae Wook Kong, Woo Young Kim, Seung-Chul Yoo, Jong-Hyuck Yoon, Ki-Hong Chang, Hee-Sug Ryu.   

Abstract

BACKGROUND: The purpose of this study was to investigate various pathologic risk factors associated with para-aortic lymph node metastasis (LNM) in surgically staged patients with endometrial cancer.
MATERIALS AND METHODS: We performed a retrospective analysis of 203 consecutive patients with endometrial cancer who were surgically staged from 2000 to 2009. The association among the various pathologic variables for para-aortic LNM was determined with univariate and multivariate analyses.
RESULTS: Of 203 patients, 29 patients (14.3%) had LNM. Also, 10 patients (4.9%) had only pelvic LNM, 14 (6.9%) had both pelvic and para-aortic LNM, and 5 (2.5%) had para-aortic LNM without pelvic LN involvements. Histologic type (P = .001), tumor grade (P < .001), tumor size (P = .003), depth of myometrial invasion (P < .001), cervical invasion (P < .001), parametrial invasion (P = .002), lymph-vascular space invasion (LVSI) (P < .001), serosal/adnexal invasion (P < .001), positive cytology (P = .002), peritoneal seeding (P < .001), and pelvic LNM (P < .001) were significant pathologic factors for para-aortic LNM. On multivariate analysis, cervical invasion (P = .032), LVSI (P = .018), and positive pelvic LNs (P = .002) were independent factors for para-aortic LNM. With regard to isolated para-aortic LNM, tumor grade (P = .017) and LVSI (P = .002) were significant factors for LN involvements. On multivariate analysis, LVSI (P = .004) was the only significant independent factor.
CONCLUSIONS: LVSI correlates significantly with the risk of isolated para-aortic LNM in endometrial cancer patients.

Entities:  

Mesh:

Year:  2010        PMID: 20607418     DOI: 10.1245/s10434-010-1206-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

Review 1.  Lymphovascular Space Invasion as a Risk Factor in Early Endometrial Cancer.

Authors:  Azmat H Sadozye; Rosie L Harrand; Nick S Reed
Journal:  Curr Oncol Rep       Date:  2016-04       Impact factor: 5.075

2.  Association of Tumor Size With Myometrial Invasion, Lymphovascular Space Invasion, Lymph Node Metastasis, and Recurrence in Endometrial Cancer: A Meta-Analysis of 40 Studies With 53,276 Patients.

Authors:  Xiaoying Jin; Chunjuan Shen; Xiaodi Yang; Yayuan Yu; Jianzhang Wang; Xuan Che
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

3.  Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases.

Authors:  Jennifer McEachron; Lila Marshall; Nancy Zhou; Van Tran; Margaux J Kanis; Constantine Gorelick; Yi-Chun Lee
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

4.  Risk group criteria for tailoring adjuvant treatment in patients with endometrial cancer: a validation study of the Gynecologic Oncology Group criteria.

Authors:  Tae Wook Kong; Suk Joon Chang; Jiheum Paek; Yonghee Lee; Mison Chun; Hee Sug Ryu
Journal:  J Gynecol Oncol       Date:  2014-11-03       Impact factor: 4.401

5.  Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study.

Authors:  Gitte Ørtoft; Lisa Lausten-Thomsen; Claus Høgdall; Estrid S Hansen; Margit Dueholm
Journal:  J Gynecol Oncol       Date:  2019-09       Impact factor: 4.401

6.  The characteristics of isolated para-aortic lymph node metastases in endometrial cancer and their prognostic significance.

Authors:  Jianbin Guo; Haili Qian; Fei Ma; Ying Zhang; Xiujuan Cui; Hua Duan
Journal:  Ther Adv Med Oncol       Date:  2020-06-13       Impact factor: 8.168

7.  Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.

Authors:  Elke E M Peters; Carla Bartosch; W Glenn McCluggage; Catherine Genestie; Sigurd F Lax; Remi Nout; Jan Oosting; Naveena Singh; Huub C S H Smit; Vincent T H B M Smit; Koen K Van de Vijver; Tjalling Bosse
Journal:  Histopathology       Date:  2019-06-10       Impact factor: 5.087

Review 8.  Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer.

Authors:  Lina Salman; Maria C Cusimano; Zibi Marchocki; Sarah E Ferguson
Journal:  Curr Oncol       Date:  2022-02-14       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.